MW 516.5 Da, Purity >95%. Originally reported to inhibit PKC isoforms, especially PKCδ and CAM-KIII. Also inhibits MAPKAP-K2 and PRAK (IC₅₀ values are 5.4 and 1.9 μM, respectively), CHK2, PLK1, PIM3 and SRPK1.
The product is subject to the following: Abcam Restricted Use Statement